Pharmacoproteomics reveals the mechanism of Chinese dragon's blood in regulating the RSK/TSC2/mTOR/ribosome pathway in alleviation of DSS-induced acute ulcerative colitis
Bibliographic Data
| ID | 14726848 |
|---|---|
| Authors | Yilong Lin (0000-0001-5134-9868, Guangxi University), Wanna Xiong (Guangxi Medical University), Simeng Xiao (Guangxi University), Fang Li (0000-0001-9180-3615, Guangxi University), Zhuo Lu (Guangxi University), Jiongyi Yan (0000-0001-8170-9182, Guangxi University), Xuewan Fang (Guangxi University), Xiaojuan Cui (0000-0002-5070-3017, Guangxi University), Yilei Wen (0000-0002-4078-2460, Guangxi University), Jianqin Liang (0000-0003-2755-8680, Guangxi University, corresponding author), Kai Yu (0000-0002-0857-1911, Guangxi University, corresponding author) |
| Year | 2020 |
| Volume | 263 |
| Pages | 113221 |
| Publication date | 2020-12-01 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Journal of Ethnopharmacology (JOURNAL) |
| Journal identifiers | ISSN: 0378-8741 • E-ISSN: 1872-7573 |
| Publisher | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.jep.2020.113221 |
| PMID | 32783984 |
| OpenAlex | W3047637392 |
| Language | EN |
| Citations received | 4 |
| References cited | 50 |
Biology · Disease · Gene · PI3K/AKT/mTOR pathway · Protein kinase B · Signal transduction · Ulcerative colitis · Western blot · Caveolin-1 and cellular processes · Chemistry · Genetic factors in colorectal cancer · Medicine · Phytochemical Studies and Bioactivities · Biochemistry · Internal Medicine · Pharmacology
Xue-Jie-San alleviates Crohn's disease through suppressing endothelial cell pyroptosis via the TLR4/NF-κB/NLRP3 pathway
Potential activity of Traditional Chinese Medicine against Ulcerative colitis
Sesquiterpene lactones-rich fraction from Aucklandia lappa Decne. alleviates dextran sulfate sodium induced ulcerative colitis through co-regulating Mapk and Nrf2/Hmox-1 signaling pathway
Xue-Jie-San prevents the early development of colitis-associated intestinal fibrosis by blocking Notch1 and FGL1 signaling pathways
| Citations per year | 1 |
|---|---|
| Citation span | 2022 - 2026 (5) |
| Highly cited | No |